Globally we are seeing an aging population with an increasing prevalence of diabetes and metabolic syndrome. Consequently, the number of patients with critical limb ischemia (CLI) is rising. Patients with CLI are at risk for both limb loss and premature death. Refinements in endovascular therapy have led to a paradigm shift in revascularization strategy in treating these complex patients.
Endovascular treatment of CLI is undergoing immense growth due to innovations in endovascular therapy. We are seeing enormous advances in both devices and procedure techniques. Patient outcomes are not all equal nor satisfactory. Increasingly we are seeing that the best outcomes occur in Centers of Excellence with dedicated limb salvage experts.
This article between 2 leading CLI Experts focuses on the inevitable movement towards identifying high quality operators and centers of excellence.
Antegrade superficial femoral artery access is safe and offers significant advantages or traditional common femoral artery access.
This paper uses data from the Vascular Quality Initiative (VQI) database to compare outcomes in patients undergoing a below the...
The SFICV EFUZEN study is the largest prospective study reporting sexual desire and function after uterine fibroid embolization (UFE).